Join our expert panelists in this roundtable webinar in recognition the inaugural GVHD Day on Friday, February 17, to discuss unmet needs in graft-versus-host disease (GVHD).

ASTCT offers its members the information, tools and forms they need to stay informed and involved in efforts to develop more effective treatments for chronic graft-versus-host disease (chronic GVHD) — an urgent unmet clinical need and the most frequent complication after HCT. This presentation is by Stella K. Kim, M.D., MD Anderson Cancer Center, and Michael R. Robinson, M.D., National Eye Institute, NIH, after the 2014 Consesn Conference on GVHD.

ASTCT offers its members the information, tools and forms they need to stay informed and involved in efforts to develop more effective treatments for chronic graft-versus-host disease (chronic GVHD) — an urgent unmet clinical need and the most frequent complication after HCT. This presentation is by Mark M. Schubert, DDS, MSD, Fred Hutchinson Cancer Research Center, after the 2014 Consesn Conference on GVHD.

ASTCT offers its members the information, tools and forms they need to stay informed and involved in efforts to develop more effective treatments for chronic graft-versus-host disease (chronic GVHD) — an urgent unmet clinical need and the most frequent complication after HCT. This presentation is by Steven Z. Pavletic, M.D., National Cancer Institute, NIH, after the 2014 Consesn Conference on GVHD.